Healthy aging
Cohort signals and animal findings; human intervention evidence is still developing.
Review the evidenceThe independent guide to L-ergothioneine
Learn what ergothioneine is, why researchers are studying it in healthy aging, where it occurs naturally, what human studies show, and how to evaluate supplements.
In 60 seconds
Ergothioneine is a naturally occurring sulfur-containing amino-acid derivative found particularly in mushrooms and certain foods. Humans obtain it through diet and possess a specialized transporter that concentrates it in selected cells and tissues.
Human research is developing. This guide shows where the science is promising—and where confident claims move beyond the evidence.
Read the complete explanation →Evidence snapshot
Conservative editorial orientations based on the verified launch literature. Not clinical recommendations.
Cohort signals and animal findings; human intervention evidence is still developing.
Review the evidenceObservational associations and one very small controlled pilot.
Review the evidenceMechanistic evidence is substantial; clinical relevance is unresolved.
Review the evidenceNo reliable controlled outcome evidence identified for clinical claims.
Review the evidenceLaboratory models support hypotheses, not proven human benefit.
Review the evidenceAn early controlled study needs independent replication.
Review the evidenceWhy ergothioneine is unusual
Established transport biology on the left; open clinical questions on the right.
Ergothioneine enters the human system mainly through diet.
Mushrooms are leading sources; content varies by species and method.
SLC22A4—also called ETT or OCTN1—supports cellular uptake.
Distribution is shaped by transporter expression, not simple diffusion.
Mechanistic plausibility must be followed by controlled human outcomes.
Food sources
Oyster, lion’s mane, shiitake, porcini and other mushrooms appear in primary food analyses, but values vary by species, growing conditions, sample preparation and measurement method.
See foods highest in ergothioneine →Quantitative values publish only after unit and citation verification.
Latest human research
Finding: The ergothioneine group improved on a learning assessment and showed a different neurofilament-light trajectory than placebo; routine blood, kidney and liver safety markers did not change.
Important limitation: Very small pilot sample; exploratory outcomes; not adequate to establish prevention or treatment of cognitive decline.
Finding: The 8 mg/day validation study reported a statistically significant improvement in subjective sleep quality versus placebo.
Important limitation: Subjective outcome; linked modeling and validation design; replication by independent groups is needed.
Finding: Lower baseline plasma ergothioneine was associated with poorer baseline performance and faster decline in several cognitive and functional measures.
Important limitation: Observational design cannot show that low ergothioneine caused decline or that supplementation would alter outcomes.
Supplement buyer’s guide
We do not rank products before verifying labels, prices, testing documentation and conflicts. Start with the fields that make a comparison reproducible.
See the buyer’s guide →